100,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 2-4 Wochen
  • Broschiertes Buch

Julien's Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations. The thoroughly updated 14th edition features: * New coverage of opioids of abuse, and drugs used to treat of opioid dependence and opioid overdose * New research on the use of marijuana to treat Alzheimers, PTSD, and Epilepsy * New coverage of pharmacological, physiological, and psychoactive effects of synthetic marijuana including its toxicity * New research on…mehr

Produktbeschreibung
Julien's Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations. The thoroughly updated 14th edition features: * New coverage of opioids of abuse, and drugs used to treat of opioid dependence and opioid overdose * New research on the use of marijuana to treat Alzheimers, PTSD, and Epilepsy * New coverage of pharmacological, physiological, and psychoactive effects of synthetic marijuana including its toxicity * New research on Cannabidiol (CBD) and its therapeutic uses * New research of the efficacy of antipsychotics to treat dementia, Parkinson's, bipolar, OCD, and PTSD * The use of genetic testing to predict effectiveness of antidepressant treatment * New research on the use of ketamine for the treatment of depression
Autorenporträt
Claire D. Advokat; Joseph E. Comaty; Robert M. Julien